**Molecular Mechanism and Rationale**
The glymphatic system represents a critical brain-wide clearance pathway that facilitates the removal of metabolic waste products and misfolded proteins associated with neurodegeneration. This perivascular network relies on aquaporin-4 (AQP4) water channels, which are predominantly expressed on astrocyte endfeet surrounding cerebral blood vessels. AQP4 forms heterotetrameric complexes that create highly efficient water-conducting pores, enabling the bulk fl
## **Molecular Mechanism and Rationale**
Aquaporin-4 (AQP4) represents the predominant water channel in the central nervous system, constituting approximately 50-60% of all aquaporin expression in astrocytes. This tetrameric transmembrane protein localizes primarily to astrocytic endfeet at the blood-brain barrier and ependymal surfaces, forming the structural foundation of the glymphatic system. Under normal physiological conditions, AQP4 facilitates bidirectional water transport across cellul
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
AQP4Vascular Barrier Glymphaticneurodegeneration
Convergent signals
AQP4 recurs across 2 selected hypotheses with aligned directionality in vascular barrier glymphatic.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
4/11
dimensions won
Treat Glymphatic Failure by Coupling AQP
7/11
dimensions won
Time-Limited AQP4 Inhibition for Acute C
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.70
0.78
Evidence
0.58
0.68
Novelty
0.72
0.65
Feasibility
0.65
0.70
Impact
0.68
0.75
Druggability
0.58
0.55
Safety
0.75
0.62
Competition
0.50
0.80
Data
0.62
0.72
Reproducible
0.60
0.70
KG Connect
0.50
0.12
Score Breakdown
Dimension
Treat Glymphatic Failure by Co
Time-Limited AQP4 Inhibition f
Mechanistic
0.700
0.780
Evidence
0.580
0.680
Novelty
0.720
0.650
Feasibility
0.650
0.700
Impact
0.680
0.750
Druggability
0.580
0.550
Safety
0.750
0.620
Competition
0.500
0.800
Data
0.620
0.720
Reproducible
0.600
0.700
KG Connect
0.500
0.118
Evidence
Treat Glymphatic Failure by Coupling AQP4-Targeted Therapy t
No evidence citations yet
Time-Limited AQP4 Inhibition for Acute Cytotoxic Edema Follo
No evidence citations yet
Debate Excerpts
Treat Glymphatic Failure by Coupling AQP4-Targeted
4 rounds · quality: 0.76
Persona-Theorist
Below are 7 therapeutic/mechanistic hypotheses for translating AQP4 biology into CNS-disorder interventions, with emphasis on Alzheimer’s disease, proteinopathies, edema/injury, and AQP4-IgG autoimmun...
{"ranked_hypotheses":[{"title":"Time-Limited AQP4 Inhibition for Acute Cytotoxic Edema Followed by Therapeutic Release","description":"Short-window AQP4 blockade (0.5-6 hours post-injury) reduces swel...
Time-Limited AQP4 Inhibition for Acute Cytotoxic E
4 rounds · quality: 0.76
Persona-Theorist
Below are 7 therapeutic/mechanistic hypotheses for translating AQP4 biology into CNS-disorder interventions, with emphasis on Alzheimer’s disease, proteinopathies, edema/injury, and AQP4-IgG autoimmun...